X

PrEP

WHO recommendation for HIV prevention

WHO recommends long-acting cabotegravir for HIV prevention: New WHO guidelines advise countries to deliver long-acting cabotegravir as part of comprehensive…

Reducing HIV risk for women

The first long-acting option to protect women from HIV, proven to reduce women's HIV risk, has been recommended for use…

HIV treatments – where we are today

HIV treatments - where we are today and what's next: Despite the ambitious 2020 goals set by UNAIDS 90-90-90 not being reached, innovative…

HIV – getting new cases down to zero

To mark World Aids Day (1st December 2018), Marc Thompson of the Terrence Higgins Trust talks about progress on reducing…

The end of HIV debate

Everyone who was there, and many people who followed the Hippocratic Post 2018, The end of HIV debate, on Twitter…

This website uses cookies.